- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03089593
Thermogenic Effect of Ginger
June 20, 2017 updated by: Adaliene Versiani M. Ferreira, Federal University of Minas Gerais
Double-blind Placebo-controlled Clinical Trial of Thermogenic Effect of Ginger (Zingiber Officinale) in Eutrophic Women
The main objective of the study is to evaluate the thermogenic effect of ginger.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Healthy and eutrophic women will receive capsules of 200 mg of ginger extract (5% active ingredient) or placebo (cellulose), along with a standardized breakfast, with a minimum seven days washout period.
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minas Gerais
-
Belo Horizonte, Minas Gerais, Brazil, 30130-100
- Hospital das Clínicas
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Females;
- Aged between 18 and 60 years old;
- Body mass index between 18.5 and 24.9 kg/m²;
- Agree to sign the informed consent.
Exclusion Criteria:
- Any chronic health conditions (e.g. diabetes, hypertension, chronic renal failure, heart and liver disease);
- Previous operation for weight loss;
- Medications known to affect total energy expenditure;
- Pregnancy and breast-feeding;
- Smoking;
- Alcohol use (>2 doses/day).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Extract of ginger
Healthy and eutrophic women will receive two capsules of 200 mg of ginger extract (5% gingerols) to be taken along with a standardized breakfast.
|
The volunteers will receive two capsules containing 200mg of extract of ginger with 5% of gingerols (20 mg).
Breakfast will be offered (bread, butter, turkey ham and industrialized fruit juice) and the participants will have 15 minutes to eat it.
|
Placebo Comparator: Cellulose
Healthy and eutrophic women will receive two capsules of 200 mg of placebo (cellulose) to be taken along with a standardized breakfast.
|
The volunteers will receive two capsules containing cellulose (placebo).
Breakfast will be offered (bread, butter, turkey ham and industrialized fruit juice) and the participants will have 15 minutes to eat it.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in postprandial energy expenditure
Time Frame: Baseline and thereafter at 30, 60, 120, 180 and 240 minutes postprandial
|
Energy expenditure will be assessed by indirect calorimetry
|
Baseline and thereafter at 30, 60, 120, 180 and 240 minutes postprandial
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in oxygen consumption
Time Frame: Baseline and thereafter at 30, 60, 120, 180 and 240 minutes postprandial
|
Oxygen consumption will be assessed by indirect calorimetry
|
Baseline and thereafter at 30, 60, 120, 180 and 240 minutes postprandial
|
Change in blood pressure
Time Frame: Baseline and thereafter at 30, 60, 120, 180 and 240 minutes postprandial
|
Blood pressure will be assessed using digital sphygmomanometer
|
Baseline and thereafter at 30, 60, 120, 180 and 240 minutes postprandial
|
Change in axillary temperature
Time Frame: Baseline and thereafter at 30, 60, 120, 180 and 240 minutes postprandial
|
Axillary temperature will be assessed using a digital thermometer
|
Baseline and thereafter at 30, 60, 120, 180 and 240 minutes postprandial
|
Change in metabolic profile
Time Frame: Baseline and thereafter at 30, 60, 120 and 240 minutes postprandial
|
Total cholesterol
|
Baseline and thereafter at 30, 60, 120 and 240 minutes postprandial
|
Change in heart rate
Time Frame: Baseline and thereafter at 30, 60, 120, 180 and 240 minutes postprandial
|
Heart rate will be assessed using digital sphygmomanometer
|
Baseline and thereafter at 30, 60, 120, 180 and 240 minutes postprandial
|
Change in metabolic profile
Time Frame: Baseline and thereafter at 30, 60, 120 and 240 minutes postprandial
|
Glucose levels
|
Baseline and thereafter at 30, 60, 120 and 240 minutes postprandial
|
Change in metabolic profile
Time Frame: Baseline and thereafter at 30, 60, 120 and 240 minutes postprandial
|
HDL-cholesterol
|
Baseline and thereafter at 30, 60, 120 and 240 minutes postprandial
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: Gabriela BP Fagundes, Federal University of Minas Gerais
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 27, 2017
Primary Completion (Actual)
June 14, 2017
Study Completion (Actual)
June 14, 2017
Study Registration Dates
First Submitted
March 8, 2017
First Submitted That Met QC Criteria
March 19, 2017
First Posted (Actual)
March 24, 2017
Study Record Updates
Last Update Posted (Actual)
June 21, 2017
Last Update Submitted That Met QC Criteria
June 20, 2017
Last Verified
June 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- UFMG 30409114.8.0000.5149
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Volunteers
-
AstraZenecaCompletedHealthy Elderly Volunteers | Healthy Young VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
University Hospital, Clermont-FerrandUnite de Nutrition Humaine UMR 1019- INRAE; Unite MetaGenoPolis INRAE; France...CompletedHealthy Volunteers | Frail VolunteersFrance
-
Galera Therapeutics, Inc.CelerionCompletedHealthy | Healthy VolunteersUnited States
-
Newcastle UniversityCompletedGI Glycaemic Index Healthy Volunteers | GL Glycaemic Load Healthy VolunteersUnited Kingdom
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
PMV Pharmaceuticals, IncRecruitingHealthy VolunteersUnited States
Clinical Trials on Extract of ginger
-
Emily DiMango, MDNational Center for Complementary and Integrative Health (NCCIH)Completed
-
University of MinnesotaCompleted
-
Federal University of Minas GeraisCompleted
-
Federal University of Minas GeraisConselho Nacional de Desenvolvimento Científico e TecnológicoUnknown
-
University of Michigan Rogel Cancer CenterNational Cancer Institute (NCI); National Center for Complementary and Integrative...CompletedUnspecified Adult Solid Tumor, Protocol Specific | Nausea and VomitingUnited States, Puerto Rico
-
Research Center for Chemistry, National Research...National Research and Innovation Agency of Indonesia; RSDC Wisma Atlet; PT. Bintang...Recruiting
-
University of MichiganCompleted
-
Chulalongkorn UniversityNot yet recruiting
-
Chulalongkorn UniversityRecruiting
-
Egas Moniz - Cooperativa de Ensino Superior, CRLCompletedHyperglycemia, PostprandialPortugal